Informace o publikaci

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Autoři

JANÍKOVÁ Andrea

Rok publikování 2015
Druh Článek v odborném periodiku
Časopis / Zdroj Leukemia and Lymphoma
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.3109/10428194.2015.1049172
Obor Ostatní lékařské obory
Klíčová slova Radiotherapy; follicular lymphoma
Popis Major changes have occurred during the last few years in the management of follicular lymphoma (FL), leading to substantial improvement in prognosis and overall survival. One of the turning points was the introduction of rituximab (R). Th is monoclonal antibody is now the cornerstone of therapy for advanced disease and is now a standard part of treatment. However, for the 25 – 30% patients with localized disease (stage I or II), involved-fi eld radiotherapy (IFRT) remains the gold standard [1]. We can indeed ask if this treatment modality is truly the gold standard?

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info